Control of NF-AT Signaling Through Nuclear Import
Control of NF-AT Signaling Through Nuclear Import
批准号:
6729113
负责人:
FRANK D. MCKEON
金额:
$27.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2006-03-31
关键词:
T lymphocytebioassaybiological signal transductioncalcineurincell differentiationcell nucleuschemical registry /resourcecytokineexpression cloninggene expressiongenetic regulationimmunoaffinity chromatographyimmunoregulationinhibitor /antagonistintermolecular interactionintracellular transportlaboratory mousemolecular sitephosphorylationprotein isoformsprotein localizationprotein structure functionprotein transporttechnology /technique developmenttissue /cell culturetranscription factor
中文摘要
描述(由申请人提供):NF-AT转录因子是关键
T细胞活化的钙信号通路中的效应物,
肌肉发育和突触可塑性。一般认为,
四种NF-AT在静息细胞中位于细胞质中,但被触发进入细胞核
并通过钙调磷酸酶(一种钙激活磷酸酶)反式激活基因。最近
然而,数据正在推翻NF-AT模型的一些假设,
为管理这只手臂的复杂调节机制提供了新的见解,
钙信号传导。例如,小鼠基因敲除四种NF-AT,
同种型已经得出了意想不到的结论,即NFAT 1和NF-AT 4在
事实上,负调节T细胞活化,而只有NF-AT 2似乎,
对细胞因子基因具有预测的阳性活性。这些数据
特别有趣的是,T细胞、肌细胞和神经元似乎
同时表达多种NF-AT同种型,表明激活必须
取决于这些因素的不同调节。我们现在已经开始
通过评估所有四种NE-AT同种型的动力学来解决这个问题,
钙信号传导和细胞环境的功能。值得注意的是,这些
数据揭示了显着程度的NE-AT同种型依赖动力学,并建议
细胞类型和钙非依赖性途径对
最终的NF-AT反应。因此,我们假设这些NF-AT家族
成员必须有区别地受到监管途径,
扩展那些由钙信号传递,并了解这些
替代机制对于预测细胞功能依赖于
在NF-AT上
这是一个建议,以揭示机制的差异NE-AT信号,
牢房我们将(1),确定潜在的生化信号通路
差异NE-AT调节及其程度;(2)阐明
钙非依赖性途径,通过高度保守的激活
在所有四种NE-AT中保守的机制;(3),通过
差分调制NE-AT动态的高通量光学屏幕
NE-AT同种型;和(4),使用这些小分子功能性剖析
NE-AT同种型对复杂过程如T
细胞激活我们预计,这种新的评估NE-AT活动,
将直接为自身免疫性疾病提供更特异的治疗方法,
器官移植和心肌病
英文摘要
DESCRIPTION (provided by applicant): The NF-AT transcription factors are key
effectors in the calcium signaling pathways underlying T cell activation,
muscle development, and synaptic plasticity. It is generally thought that the
four NF-ATs are cytoplasmic in resting cells but triggered to enter the nucleus
and transactivate genes by calcineurin, a calciumactivated phosphatase. Recent
data, however, are overturning some of the assumptions of the NF-AT model and
offering new insights to the complex regulatory mechanisms governing this arm
of calcium signaling. For instance, mouse gene knockouts of the four NF-AT
isotypes have rendered the unexpected conclusion that NFAT1 and NF-AT4 are in
fact negative regulators of T cell activation, while only NF-AT2 appears to
have the predicted positive activity towards cytokine genes. These data are
especially interesting because T cells, myocytes, and neurons appear to
simultaneously express multiple NF-AT isotypes, indicating that activation must
depend on the differential regulation of these factors. We have now begun to
address this problem by evaluating the dynamics of all four NE-AT isotypes as a
function of calcium signaling and cellular environment. Significantly, these
data reveal a remarkable degree of NE-AT isotype-dependent dynamics and suggest
important contributions of cell type and calcium-independent pathways to the
ultimate NF-AT response. We hypothesize, therefore, that these NF-AT family
members must be differentially subject to regulatory pathways that override or
extend those imparted by calcium signaling, and that understanding these
alternative mechanisms is essential for predicting cellular functions dependent
on NF-ATs.
This is a proposal to uncover the mechanisms of differential NE-AT signaling in
the cell. We will (1), determine the biochemical signaling pathways underlying
differential NE-AT regulation and their extent; (2) elucidate the
calcium-independent pathways that operate through a highly conserved activation
mechanism conserved in all four NE-ATs; (3), identify small molecules through
high-throughput optical screens of NE-AT dynamics which differentially modulate
the NE-AT isotypes; and (4), use these small molecules to functionally dissect
the individual contributions of NE-AT isotypes to complex processes such as T
cell activation. We anticipate that this novel evaluation of NE-AT activity
will directly contribute to more specific therapies for autoimmune disease,
organ transplantation, and cardiomyopathies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
-
批准号:10367503
-
项目类别:
-
资助金额:$69.18万
-
财政年份:2022
-
负责人:FRANK D. MCKEON
-
依托单位:
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence
-
批准号:10607403
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2022
-
负责人:FRANK D. MCKEON
-
依托单位:
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
-
批准号:10557166
-
项目类别:
-
资助金额:$67.81万
-
财政年份:2022
-
负责人:FRANK D. MCKEON
-
依托单位:
Clonal Reconstruction and Targeting of the Correa Sequence
-
批准号:10470091
-
项目类别:
-
资助金额:$55.08万
-
财政年份:2019
-
负责人:FRANK D. MCKEON
-
依托单位:
Clonal Reconstruction and Targeting of the Correa Sequence
-
批准号:9980818
-
项目类别:
-
资助金额:$56.2万
-
财政年份:2019
-
负责人:FRANK D. MCKEON
-
依托单位:
Clonal Reconstruction and Targeting of the Correa Sequence
-
批准号:10194421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:FRANK D. MCKEON
-
依托单位:
Clonal Reconstruction and Targeting of the Correa Sequence
-
批准号:10671032
-
项目类别:
-
资助金额:$55.08万
-
财政年份:2019
-
负责人:FRANK D. MCKEON
-
依托单位:
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence
-
批准号:9761508
-
项目类别:
-
资助金额:$17.46万
-
财政年份:2017
-
负责人:FRANK D. MCKEON
-
依托单位:
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence
-
批准号:9551729
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2017
-
负责人:FRANK D. MCKEON
-
依托单位:
Monoclonal Antibodies and Genetic Elements for Airway Disease
-
批准号:7827314
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:FRANK D. MCKEON
-
依托单位:
p63-Dependent Checkpoints in Oocytes
-
批准号:7900949
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2009
-
负责人:FRANK D. MCKEON
-
依托单位:
p63-Dependent Checkpoints in Oocytes
-
批准号:7652006
-
项目类别:
-
资助金额:$48.47万
-
财政年份:2009
-
负责人:FRANK D. MCKEON
-
依托单位:
Monoclonal Antibodies and Genetic Elements for Airway Disease
-
批准号:7935337
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2009
-
负责人:FRANK D. MCKEON
-
依托单位:
Epithelial Stem Cell Programs
-
批准号:7662450
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2008
-
负责人:FRANK D. MCKEON
-
依托单位:
Epithelial Stem Cell Programs
-
批准号:8074103
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:FRANK D. MCKEON
-
依托单位:
Epithelial Stem Cell Programs
-
批准号:7525372
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2008
-
负责人:FRANK D. MCKEON
-
依托单位:
Epithelial Stem Cell Programs
-
批准号:7845493
-
项目类别:
-
资助金额:$37.76万
-
财政年份:2008
-
负责人:FRANK D. MCKEON
-
依托单位:
Mitotic Checkpoint Proteins in Tumorigenesis
-
批准号:6912547
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2002
-
负责人:FRANK D. MCKEON
-
依托单位:
Control of NF-AT Signaling Through Nuclear Import
-
批准号:6624409
-
项目类别:
-
资助金额:$32.68万
-
财政年份:2002
-
负责人:FRANK D. MCKEON
-
依托单位:
Control of NF-AT Signaling Through Nuclear Import
-
批准号:6474782
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2002
-
负责人:FRANK D. MCKEON
-
依托单位:
国内基金
海外基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
-
批准号:41606166
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:彭吉星
-
依托单位: